At our recent Warwick testing event, we assisted TestCard with the ongoing development of a new type of lateral flow PSA test. From TestCard: "We are very grateful to all the men who volunteered their time for an additional step of a finger prick so that we at TestCard can validate a rapid diagnostic test for PSA that could be used at home. Our test is a lateral flow test, very similar to the Covid antigen tests that everyone has become very familiar with over the last few ye...

Prostate cancer treatment is evolving, with innovative approaches offering new hope to patients seeking effective solutions with fewer side effects. One such advancement is High-Intensity Focused Ultrasound (HIFU)—a minimally invasive focal therapy that targets cancerous prostate tissue while preserving surrounding healthy cells. What is HIFU Therapy? HIFU harnesses the power of highly focused ultrasound waves to heat and destroy cancer cells within the prostate. This precis...

Please join us on this beautiful trek in the Annapurna region of Nepal in Oct 2025 for this incredible challenge to raise money for PSA testing!  BEDS & GFCT - PSA Test Fundraiser October 17, 2025 - October 26, 2025 A challenging and exhilarating trek in the Annapurna region that offers breathtaking views of the Himalayan mountain range. Fundraised money will fund prostate-specific antigen (PSA) tests. £500 helps us to subsidise 40 tests.  "If you are...

GFCT Conference – 28 November 2024 – CANCELLED It is with regret that we must cancel our conference next week. The hotel has been taken over at very short notice by the Home Office as accommodation for asylum seekers. As you can appreciate, it has proved extremely difficult to find another venue that can accommodate our event. We will be looking to reschedule our conference for March next year.

The moment when Sir Chris Hoy went public about the fact that at the age of forty-eight, he had been diagnosed with terminal prostate cancer he went from "National Olympic hero" to "National Treasure" in my opinion. As a prostate cancer awareness charity established 20 years ago and who've been involved in helping carry out well over 300,000 PSA tests leading to over 3,200 cancer finds in that time, we've seen several spikes in awareness following similar pu...

We are delighted to announce that Mr Graham Fulford, Founder and Trustee of The Graham Fulford Charitable Trust was presented with his MBE by Tim Cox Lord Lieutenant of Warwickshire on 30th October 2024. Graham was awarded the MBE in the King’s Birthday Honours on Saturday the 15th June 2024 for services to prostate cancer awareness and earlier diagnosis. The Member of the Order of the British Empire (MBE) is a prestigious honour awarded by the British monarchy to ...

In a new BBC interview, Sir Chris Hoy, six-time Olympic cycling champion, aged only 48, discussed his personal battle with terminal prostate cancer. Since his diagnosis in September 2023, Sir Chris has shared his experiences to raise awareness about prostate cancer, contributing to a surge in NHS searches on the topic. Reflecting on the physical and emotional challenges, he revealed how he copes with chemotherapy through mental resilience and support from family. Remarkably, both he an...

Such a powerful testimonial, a must read... "Dear Sirs, I should have written this thank you note a long time ago, but I guess better late than never. Back in May 2022, you held a blood test session at Luton Town Football Club, and I attended. My Dad had died of prostate cancer because he avoided the issue - and that was not going to happen to me. I’d had a test at my doctors and was told I had an enlarged prostate - but nothing to worry about apparently. &nbs...

Menopause isn’t just a “hot topic”; it’s a significant life stage for millions of women globally, marking the end of their reproductive years. Yet, for many, it arrives with more questions than answers. Did you know that we offer a Female Hormones Test for menopause? What is Menopause?Menopause is a natural biological process that usually occurs between the ages of 45 and 55, signalling the end of menstrual cycles due to changes in hormone levels. While menopause is ...

The NHS is conducting a groundbreaking trial of a home-based spit test designed to assess prostate cancer risk, with a strong focus on addressing disparities affecting Black men, who face double the risk of prostate cancer compared to other groups. Developed by the Institute of Cancer Research, the test works by analysing DNA from saliva, identifying genetic markers linked to high prostate cancer risk. Previously, the saliva test in 2016 was limited to white people of European ancestry due ...